Atossa Therapeutics
ATOS
#9991
Rank
NZ$77.78 M
Marketcap
NZ$9.03
Share price
-0.74%
Change (1 day)
525.20%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.42. In 2024 the company made an earnings per share (EPS) of NZ-$0.34 an increase over its 2023 EPS that were of NZ-$0.41.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4223.44%
2024NZ-$0.34-16.67%
2023NZ-$0.4114.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.34-2.96%
2019NZ-$3.44-63.09%
2018NZ-$9.32-49.63%
2017NZ-$18.51-57.87%
2016NZ-$43.93-74.01%
2015NZ-$169.01-9.18%
2014NZ-$186.09-12.86%
2013NZ-$213.5470.73%
2012NZ-$125.0834.08%
2011NZ-$93.29263.47%
2010NZ-$25.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.88-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.03-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.85-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.42 236.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA